IBACR Seeks 6-Month Extension for Business Combination Deadline

TL;DR

**Vote YES on the extension, or IBACR is dead money by September 28, 2025, and you're just getting your cash back.**

AI Summary

IB Acquisition Corp. (IBACR) is seeking stockholder approval to extend its deadline for consummating a business combination by six months, from September 28, 2025, to March 28, 2026. This extension requires amending the company's amended and restated articles of incorporation and the Investment Management Trust Agreement, dated March 25, 2024. The Board of Directors believes this additional time is crucial as they do not expect to complete an initial business combination by the current September 28, 2025 deadline. If the extension is not approved, IB Acquisition Corp. will be forced to liquidate, redeeming 100% of its public shares at a per-share price derived from the Trust Account balance, and its rights will expire worthless. The approval of Proposal 1 requires an affirmative vote of 65% of the outstanding shares, while Proposal 2 requires a majority. As of the record date, September 3, 2025, there were 15,749,090 shares of common stock outstanding.

Why It Matters

This DEF 14A filing is critical for IBACR investors as it directly impacts the SPAC's ability to complete a merger. Without the proposed six-month extension to March 28, 2026, the company faces mandatory liquidation by September 28, 2025, which would result in public stockholders receiving only their pro-rata share of the Trust Account. For employees and potential target companies, a liquidation means no deal and lost opportunities. In the competitive SPAC market, securing an extension signals ongoing efforts to find a suitable target, but also highlights challenges in deal sourcing within the initial timeframe.

Risk Assessment

Risk Level: high — The risk level is high because failure to approve Proposal 1 (the extension) by a 65% affirmative vote of outstanding shares will lead to the immediate liquidation of IB Acquisition Corp. by September 28, 2025. This means the company will cease operations and redeem 100% of public shares, extinguishing all rights, including the right to receive further liquidating distributions, if any, and rendering the company's rights worthless.

Analyst Insight

Investors should carefully consider the implications of a 'no' vote, which would trigger liquidation and a return of capital. A 'yes' vote provides the SPAC more time to identify and close a business combination, offering potential upside but also extending the investment horizon and associated market risks.

Key Numbers

• September 28, 2025 — Current business combination deadline (Date by which IB Acquisition Corp. must complete a merger or liquidate)
• March 28, 2026 — Proposed extended business combination deadline (New deadline if the extension proposal is approved)
• 65% — Required vote for Proposal 1 (Affirmative vote of outstanding shares needed to approve the charter amendment for extension)
• 15,749,090 — Shares of common stock outstanding (Total shares entitled to vote as of the September 3, 2025 record date)
• 3,243,590 — Founder Shares (Shares held by Sponsor, independent directors, and I-Bankers Securities, Inc.)
• $7,500 — Fee for proxy solicitation (Base fee to be paid to Advantage Proxy)
• $1,000 — Fee for extension meeting (Additional fee to Advantage Proxy for any extension meeting)
• 18.0% — I-B Good Works 4, LLC ownership (Percentage of outstanding common stock beneficially owned)
• 6.5% — James Michael McCrory ownership (Percentage of outstanding common stock beneficially owned)
• September 3, 2025 — Record Date (Date for determining stockholders eligible to vote at the Special Meeting)

Key Players & Entities

• IB Acquisition Corp. (company) — Registrant seeking extension
• Al Lopez (person) — Chief Executive Officer of IB Acquisition Corp.
• Continental Stock Transfer & Company (company) — Trustee for the Investment Management Trust Agreement
• I-B Good Works 4, LLC (company) — 5% beneficial owner with 18.0% of outstanding common stock
• James Michael McCrory (person) — 5% beneficial owner with 6.5% of outstanding common stock
• Advantage Proxy (company) — Proxy solicitation firm engaged for the Special Meeting
• SEC (regulator) — Securities and Exchange Commission
• I-Bankers Securities, Inc. (company) — Holder of Founder Shares

FAQ

Risk Factors

• Liquidation Risk Without Business Combination [high — financial]: Failure to approve the extension proposal (Proposal 1) will result in IB Acquisition Corp. liquidating and redeeming 100% of its public shares. This outcome is driven by the company's expectation that it will not complete an initial business combination by the current deadline of September 28, 2025.
• Vote Requirement for Extension [high — regulatory]: Approval of the charter amendment to extend the business combination deadline (Proposal 1) requires an affirmative vote of 65% of the outstanding shares. As of September 3, 2025, there were 15,749,090 shares outstanding, meaning approximately 10,236,908 shares must vote in favor.
• Dependence on Trust Account for Redemptions [medium — operational]: In the event of liquidation, public stockholders will receive a per-share price derived from the Trust Account balance. The company's ability to meet these redemption obligations is directly tied to the funds held within this trust.
• Expiration of Rights [high — legal]: If the business combination is not consummated by the deadline and the extension is not approved, the company's rights will expire worthless. This implies a complete loss of value for any outstanding rights associated with the company's structure.

Industry Context

IB Acquisition Corp. operates within the Special Purpose Acquisition Company (SPAC) sector. This industry has seen significant activity, with many SPACs formed to identify and merge with private companies. However, the market is also characterized by increasing regulatory scrutiny and a challenging environment for completing business combinations within the typical two-year timeframe, leading to a rise in extension requests.

Regulatory Implications

The primary regulatory implication for IB Acquisition Corp. is the requirement for a supermajority vote (65%) to approve the charter amendment for the extension. This high threshold, coupled with the potential for liquidation if the vote fails, highlights the importance of shareholder alignment and the SEC's oversight of SPAC activities.

What Investors Should Do

1. Vote on Proposal 1 (Extension Amendment)
2. Vote on Proposal 2 (Trust Agreement Amendment)
3. Review Proxy Materials Carefully
4. Vote Promptly

Key Dates

• 2025-09-28: Current Business Combination Deadline — The company must complete a business combination by this date or face liquidation.
• 2026-03-28: Proposed Extended Business Combination Deadline — This is the new deadline if stockholders approve the extension proposal, providing additional time to find and complete a merger.
• 2025-09-22: Special Meeting of Stockholders — The date for stockholders to vote on the extension proposal and other related matters.
• 2025-09-03: Record Date — Determines which stockholders are eligible to vote at the Special Meeting.
• 2024-03-25: Investment Management Trust Agreement Dated — This agreement governs the funds held in trust and is subject to amendment for the extension.

Glossary

DEF 14A

A filing with the U.S. Securities and Exchange Commission (SEC) that provides detailed information to shareholders about matters on which they are being asked to vote. (This document is the proxy statement detailing the proposals for the IB Acquisition Corp. special meeting.)

Business Combination

In the context of a Special Purpose Acquisition Company (SPAC) like IB Acquisition Corp., this refers to the merger, capital exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. (The core objective of IB Acquisition Corp. is to complete a business combination before its deadline.)

Trust Account

An account established by a SPAC to hold the proceeds from its initial public offering (IPO) in trust, which are typically used to fund the business combination or returned to shareholders upon liquidation. (The balance of the Trust Account determines the per-share redemption price if IB Acquisition Corp. liquidates.)

SPAC

Special Purpose Acquisition Company. A shell company that is created to raise capital through an initial public offering (IPO) for the purpose of acquiring an existing company. (IB Acquisition Corp. is a SPAC seeking to complete a business combination.)

Redemption

The act of a company buying back its own shares from shareholders, typically at a specified price. In SPACs, this often occurs if a business combination is not completed by the deadline. (Public shares of IB Acquisition Corp. will be redeemed at the Trust Account balance if the extension is not approved.)

Proxy Card

A document that authorizes a designated person (the proxy) to vote a shareholder's shares at a shareholder meeting in accordance with the shareholder's instructions. (Stockholders will use a proxy card to vote on the proposals at the Special Meeting.)

Year-Over-Year Comparison

This DEF 14A filing is focused on seeking shareholder approval for an extension of the business combination deadline. Unlike a typical annual report, it does not present comparative financial statements or revenue growth figures. The key comparison is to the company's current deadline of September 28, 2025, versus the proposed extended deadline of March 28, 2026, driven by the company's inability to complete a business combination within the original timeframe.

Key Financial Figures

• $7,500 — at we will pay Advantage Proxy a fee of $7,500 plus a $1,000 fee for any extension mee
• $1,000 — Advantage Proxy a fee of $7,500 plus a $1,000 fee for any extension meeting. We will
• $100,000 — erest (net of taxes payable, less up to $100,000 of such net interest to pay dissolution
• $115.575 million — y a small fraction of the approximately $115.575 million that was in the Trust Account as of the
• $5,000,001 — ublic shares cause us to have less than $5,000,001 of net tangible assets following approv

Filing Documents

• formdef14a.htm (DEF 14A) — 263KB
• proxy_001.jpg (GRAPHIC) — 495KB
• proxy_002.jpg (GRAPHIC) — 280KB
• 0001641172-25-026995.txt ( ) — 1333KB

From the Filing

DEF 14A 1 formdef14a.htm DEF 14A UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to §240.14a-12 IB Acquisition Corp. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. IB ACQUISITION CORP. 1200 N Federal Highway, Suite 215 Boca Raton, FL 33432 To the Stockholders of IB Acquisition Corp.: You are cordially invited to attend a special meeting of stockholders of IB Acquisition Corp. on September 22, 2025, at 10:00 a.m. Eastern Time. The special meeting will be a completely virtual meeting of stockholders, which will be conducted via live webcast. You will be able to attend the special meeting online, vote and submit your questions during the special meeting by visiting https://www.cstproxy.com/ibacquisition/2025 . If you plan to attend the virtual online special meeting, you will need the control number found on your proxy card, voting instruction form or notice. Information regarding each of the matters to be voted on at the special meeting is contained in the attached Proxy Statement and Notice of Special Meeting of Stockholders. We urge you to read the proxy statement carefully. The proxy statement and proxy card are being mailed on or about September 9, 2025 to all stockholders of record as of September 3, 2025. Your vote is very important, regardless of the number of shares of our voting securities that you own. Whether or not you expect to attend the virtual Special Meeting, please vote as promptly as possible to ensure your representation and the presence of a quorum at the Special Meeting. Only stockholders who held shares at the close of business on the record date, September 3, 2025, may vote at the special meeting. As an alternative to voting online during the special meeting, you may vote in advance of the special meeting, via the Internet, by telephone, or by signing, dating and returning the proxy card. If your shares are held in the name of a broker, trust, bank or other nominee, and you receive these materials through your broker or through another intermediary, please complete and return the materials in accordance with the instructions provided to you by such broker or other intermediary or contact your broker directly in order to obtain a proxy issued to you by your nominee holder to attend the meeting and vote in person. Failure to do so may result in your shares not being eligible to be voted by proxy at the special meeting. We look forward to seeing you virtually on September 22, 2025. Very truly yours, IB Acquisition Corp. By: /s/ Al Lopez Al Lopez Chief Executive Officer Important Notice Regarding the Availability of Proxy Materials for the Special Meeting of Stockholders to be Held on September 22, 2025: Electronic Copies of this notice of meeting and the Proxy Statement are available at https://www.cstproxy.com/ibacquisition/2025 2 IB ACQUISITION CORP. 1200 N Federal Highway, Suite 215 Boca Raton, FL 33432 NOTICE OF SPECIAL MEETING OF STOCKHOLDERS To Be Held September 22, 2025 TO THE STOCKHOLDERS OF IB ACQUISITION CORP.: NOTICE IS HEREBY GIVEN that a Special Meeting of Stockholders (the “Special Meeting”) of IB Acquisition Corp. (the “Company”) will be held on September 22, 2025, at 10:00 a.m. Eastern Time. The Special Meeting will be a completely virtual meeting of stockholders, which will be conducted via live webcast. You will be able to attend the Special Meeting online, vote and submit your questions during the Special Meeting by visiting https://www.cstproxy.com/ibacquisition/2025 . If you plan to attend the virtual online Special Meeting, you will need the control number found on your proxy card, voting instruction form or notice. The Special Meeting will be held for the sole purpose of considering and voting upon the following proposals: 1. To approve an amendment to the Company’s amended and restated articles of incorporation to extend the date by which the Company must consummate a business combination or, if it fails to do so, cease its operations and redeem or repurchase 100% of the shares of the Company’s common stock issued in the Company’s initial public offering (“IPO”), by six (6) months from September 28, 2025 to March 28, 2026. 2. To amend the Investment Management Trust Agreement, dated March 25, 2024, by and bet

View Full Filing

View this DEF 14A filing on SEC EDGAR